Nathan Teuscher, PhD

Dr. Teuscher brings over 20 years of extensive expertise in pharmacometrics and clinical pharmacology to the forefront of the pharmaceutical industry. Throughout his career, he has demonstrated a keen interest in leveraging data to enhance our understanding of the safety and efficacy of therapeutics and diagnostics. Dr. Teuscher’s diverse professional journey has seen him assume scientific and leadership roles across various sectors, including biotechnology companies, contract research organizations, mid-size pharmaceutical companies, and large consultancies.

As a seasoned leader, Dr. Teuscher has made significant contributions to the field, including his tenure leading the software development team at Certara, where he played a pivotal role in driving innovation and advancing scientific research. His passion for empowering scientists and companies to harness the power of data is evident in his creation of the “Learn PKPD” blog in 2008, which has served as a valuable resource for professionals seeking to deepen their understanding of pharmacokinetics and pharmacodynamics.

In addition to his prolific blogging efforts, Dr. Teuscher hosts bi-monthly podcasts on Clinical Pharmacology, Medical, and Manuscript Writing, further enriching the knowledge-sharing landscape within the industry. His dedication to disseminating knowledge and facilitating dialogue underscores his commitment to advancing the field of pharmaceutical sciences.

Dr. Teuscher’s scholarly contributions extend beyond his digital platforms, with 35 publications, posters, and abstracts to his credit. His innovative research has earned him recognition in the form of one patent, highlighting his creative approach to addressing complex scientific challenges.
Dr. Teuscher holds a Bachelor of Science in Biochemistry from Brigham Young University, as well as a Master of Science and Ph.D. in Pharmaceutical Sciences from the University of Michigan. His multidisciplinary educational background, combined with his wealth of industry experience, positions him as a distinguished leader and influencer in pharmacometrics and clinical pharmacology.